|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
4
|
Zenith Epigenetics
|
Feb 28, 2022 11:59AM
|
|
Re: Next question
|
2
|
Resverlogix Corp.
|
Apr 02, 2024 05:29PM
|
|
Re: Next question
|
1
|
Resverlogix Corp.
|
Apr 02, 2024 08:47PM
|
|
Re: Next question
|
1
|
Resverlogix Corp.
|
Apr 02, 2024 01:41PM
|
|
Re: nice drop!
|
2
|
Resverlogix Corp.
|
Feb 24, 2020 05:54PM
|
|
Re: Nice problem to have....
|
2
|
Resverlogix Corp.
|
Mar 02, 2020 12:18PM
|
|
Re: Nice run for Hepa over the holidays
|
2
|
Resverlogix Corp.
|
Jan 06, 2020 01:00PM
|
|
Re: Nice run for Hepa over the holidays
|
4
|
Resverlogix Corp.
|
Jan 06, 2020 08:57PM
|
|
Re: Nice run for Hepa over the holidays
|
4
|
Resverlogix Corp.
|
Jan 07, 2020 10:39AM
|
|
Re: Nice to read one employee's assessment about EVERSANA.
|
5
|
Resverlogix Corp.
|
Jul 14, 2021 12:45PM
|
|
Re: Nine Months, 2021- Financials and MD&A on SEDAR
|
4
|
Resverlogix Corp.
|
Nov 14, 2021 10:18AM
|
|
Re: Nine Months, 2021- Financials and MD&A on SEDAR
|
2
|
Resverlogix Corp.
|
Nov 14, 2021 01:50PM
|
|
Re: NKF pres
|
6
|
Resverlogix Corp.
|
Mar 23, 2020 11:23AM
|
|
Re: no bids or asks on the TD plat this morn?? - anyone seeing anything?
|
2
|
Zenith Epigenetics
|
Sep 28, 2021 10:44AM
|
|
Re: No change in Ottawa.
|
7
|
Resverlogix Corp.
|
Sep 22, 2021 11:08AM
|
|
Re: No mention of efficacy again...
|
4
|
Resverlogix Corp.
|
Mar 29, 2019 09:30AM
|
|
Re: No mention of efficacy again...
|
1
|
Resverlogix Corp.
|
Mar 29, 2019 09:31AM
|
|
Re: Not adding up!
|
2
|
Zenith Epigenetics
|
Nov 15, 2021 11:40AM
|
|
Re: Not adding up!
|
2
|
Zenith Epigenetics
|
Nov 15, 2021 01:17PM
|
|
Re: Not adding up!
|
2
|
Zenith Epigenetics
|
Nov 15, 2021 02:05PM
|
